Dr. Sammita Satyanarayan, MD

Dr. Satyanarayan practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Satyanarayan's NPI, 1639531882, was assigned on March 27, 2016. Dr. Satyanarayan graduated from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine in 2016. Dr. Satyanarayan holds New York license 304018.

Dr. Satyanarayan's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Satyanarayan also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Satyanarayan's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. Dr. Satyanarayan is also affiliated with Mount Sinai Beth Israel. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Satyanarayan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Satyanarayan practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Satyanarayan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Satyanarayan is licensed in New York.

CMS data shows 35 Medicare services from Dr. Satyanarayan across 2 procedure codes in 2024, for 65 Medicare patients. Medicare paid $4,414 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 65 Medicare patients who saw Dr. Satyanarayan in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 42% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Satyanarayan's median patient age at 48, with 69% women.

In 2024, Dr. Satyanarayan wrote 244 Medicare Part D claims for 27 patients. 77% of them were for generic drugs. CMS names the drug for 136 of them, across 7 drugs with 11 or more claims each, at $278,593 in total drug cost. In 2023, CMS named 90 claims across 5 drugs.

Dr. Satyanarayan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Satyanarayan as offering telehealth.

Dmand AI links 6 papers to Dr. Satyanarayan, published from 2019 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Multiple Sclerosis and Immunosuppressive Agents. Dr. Satyanarayan's most frequent co-authors are Fred Lublin, MD, Michelle Therese Fabian, MD and Sam H. Horng, MD.

CMS Open Payments shows 7 general payments to Dr. Satyanarayan from 4 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 94% of the total. EMD Serono, Inc. paid the most, $3,176. It also lists 1 research payment totaling $3,375 in 2025.

Dr. Satyanarayan graduated from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine in 2016.